CVAC — CureVac NV Cashflow Statement
0.000.00%
Last trade - 00:00- $727.25m
- $219.96m
- €535.18m
- 80
- 96
- 57
- 92
Annual cashflow statement for CureVac NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -130 | -412 | -249 | -260 | 191 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 40.2 | -350 | 67.7 | 27.4 | 15.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 602 | 15.4 | -129 | -58.6 | -123 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 522 | -733 | -286 | -268 | 102 |
| Capital Expenditures | -47.4 | -128 | -93.2 | -55.2 | -18.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 2.08 | 0 | -0.277 | 0 | 0 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -45.3 | -128 | -93.5 | -55.2 | -18.4 |
| Financing Cash Flow Items | — | — | 66.5 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 820 | 345 | 63.2 | 231 | -5.11 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,292 | -511 | -316 | -93.3 | 79.3 |